165 related articles for article (PubMed ID: 15932357)
1. How Guillain-Barre patients experience their functioning after 1 year.
Bernsen RA; de Jager AE; van der Meché FG; Suurmeijer TP
Acta Neurol Scand; 2005 Jul; 112(1):51-6. PubMed ID: 15932357
[TBL] [Abstract][Full Text] [Related]
2. The effects of Guillain-Barré syndrome on the close relatives of patients during the first year.
Bernsen RA; de Jager AE; van der Meché FG; Suurmeijer TP
J Neurol Sci; 2006 May; 244(1-2):69-75. PubMed ID: 16476450
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial dysfunction in the first year after Guillain-Barré syndrome.
Bernsen RA; de Jager AE; Kuijer W; van der Meché FG; Suurmeijer TP
Muscle Nerve; 2010 Apr; 41(4):533-9. PubMed ID: 19941334
[TBL] [Abstract][Full Text] [Related]
4. [Outcome after Guillain-Barré syndrome: comparison of motor function status and changes in social life].
Nagashima T; Nishimoto Y; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Jan; 44(1):50-3. PubMed ID: 15199739
[TBL] [Abstract][Full Text] [Related]
5. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
Dornonville de la Cour C; Jakobsen J
Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
[TBL] [Abstract][Full Text] [Related]
6. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
Korinthenberg R; Schessl J; Kirschner J; Mönting JS
Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
[TBL] [Abstract][Full Text] [Related]
7. Impairment in Guillain-Barré syndrome during the first 2 years after onset: a prospective study.
Forsberg A; Press R; Einarsson U; de Pedro-Cuesta J; Widén Holmqvist L;
J Neurol Sci; 2004 Dec; 227(1):131-8. PubMed ID: 15546603
[TBL] [Abstract][Full Text] [Related]
8. Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?
Rudolph T; Larsen JP; Farbu E
Acta Neurol Scand; 2009 Nov; 120(5):347-52. PubMed ID: 19744135
[TBL] [Abstract][Full Text] [Related]
9. The long-term functional status in patients with Guillain-Barré syndrome.
Rudolph T; Larsen JP; Farbu E
Eur J Neurol; 2008 Dec; 15(12):1332-7. PubMed ID: 19049550
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification in Guillain-Barré syndrome: incidence and effects on functional outcome with long-term follow-up.
Zeilig G; Weingarden HP; Levy R; Peer I; Ohry A; Blumen N
Arch Phys Med Rehabil; 2006 Jan; 87(1):92-5. PubMed ID: 16401445
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of Guillain-Barré syndrome in children.
Roodbol J; de Wit MC; Aarsen FK; Catsman-Berrevoets CE; Jacobs BC
J Peripher Nerv Syst; 2014 Jun; 19(2):121-6. PubMed ID: 24863162
[TBL] [Abstract][Full Text] [Related]
13. Long-term impact on work and private life after Guillain-Barré syndrome.
Bernsen RA; de Jager AE; Schmitz PI; van der Meché FG
J Neurol Sci; 2002 Sep; 201(1-2):13-17. PubMed ID: 12163188
[TBL] [Abstract][Full Text] [Related]
14. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
16. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.
Cochen V; Arnulf I; Demeret S; Neulat ML; Gourlet V; Drouot X; Moutereau S; Derenne JP; Similowski T; Willer JC; Pierrot-Deseiligny C; Bolgert F
Brain; 2005 Nov; 128(Pt 11):2535-45. PubMed ID: 16000335
[TBL] [Abstract][Full Text] [Related]
17. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit.
Dhar R; Stitt L; Hahn AF
J Neurol Sci; 2008 Jan; 264(1-2):121-8. PubMed ID: 17881005
[TBL] [Abstract][Full Text] [Related]
18. Falling ill with Guillain-Barré syndrome: patients' experiences during the initial phase.
Forsberg A; Ahlström G; Holmqvist LW
Scand J Caring Sci; 2008 Jun; 22(2):220-6. PubMed ID: 18489692
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome.
Drory VE; Bronipolsky T; Bluvshtein V; Catz A; Korczyn AD
J Neurol Sci; 2012 May; 316(1-2):72-5. PubMed ID: 22336700
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
